David M. Lonard

7.9k citations

89 papers · 6.0k · h-index 38

Impact in

Genetics top 0.5%
- Estrogen and related hormone effects
Molecular Biology top 1%
- Ubiquitin and proteasome pathways
- Retinoids in leukemia and cellular processes
- RNA Research and Splicing
- Protein Degradation and Inhibitors
- Genomics and Chromatin Dynamics

Papers in

Molecular Biology 53
- Ubiquitin and proteasome pathways 19
- Protein Degradation and Inhibitors 12
- Genomics and Chromatin Dynamics 9
- Retinoids in leukemia and cellular processes 7
- RNA Research and Splicing 7
Genetics 45
- Estrogen and related hormone effects 42

Co-authors: Bert W. O’Malley (70 shared papers)Zafar Nawaz (5 shared papers)Carolyn L. Smith (3 shared papers)Sophia Y. Tsai (8 shared papers)Ming‐Jer Tsai (8 shared papers)Qin Feng (6 shared papers)Rainer B. Lanz (6 shared papers)C. Smith (3 shared papers)
Journals: Proceedings of the National Academy of Sciences (6 papers)Molecular Cell (6 papers)Molecular Endocrinology (6 papers)PLoS ONE (5 papers)Cancer Research (4 papers)
Partner nations: United States China Israel

In The Last Decade

David M. Lonard

86 papers receiving 6.0k citations

Peers

Replace Debabrata Chakravarti with:

Debabrata Chakravarti United States

Rainer B. Lanz United States

Jennifer K. Richer United States

Joseph Torchia Canada

A. Krust France

Lan Xu United States

Aria Baniahmad Germany

A. Raymond Frackelton United States

Shaun M. Cowley United Kingdom

Xiao Hu United States

David M. Lonard relative to Debabrata Chakravarti United States Debabrata Chakravarti's profile →

Citations per field

00.5×1.5×

Debabrata Chakravarti · 1×

×1.2 3k/2k

GENET

×0.7 4k/6k

MB

×1.1 1k/1k

ONCOL

×0.7 669/965

CR

×0.7 669/918

IMMUN

Citations per year

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

'26

Countries citing papers authored by David M. Lonard

Since Specialization

Citations

This map shows the geographic impact of David M. Lonard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Lonard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Lonard more than expected).

Fields of papers citing papers by David M. Lonard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Lonard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Lonard. The network helps show where David M. Lonard may publish in the future.

Co-authors

The 25 scholars most cited alongside David M. Lonard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David M. Lonard Line = papers co-authored together David M. Lonard links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Proteasome-dependent degradation of the human estrogen receptor Proceedings of the National Academy of Sciences ·Zafar Nawaz, David M. Lonard, Andrew P. Dennis, Carolyn L. Smith, Bert W. O’Malley	1999	499
2	The 26S Proteasome Is Required for Estrogen Receptor-α and Coactivator Turnover and for Efficient Estrogen Receptor-α Transactivation Molecular Cell ·David M. Lonard, Zafar Nawaz, Carolyn L. Smith, Bert W. O’Malley	2000	475
3	Nuclear Receptor Coregulators: Judges, Juries, and Executioners of Cellular Regulation Molecular Cell ·David M. Lonard, Bert W. O’Malley	2007	371
4	The Angelman Syndrome-Associated Protein, E6-AP, Is a Coactivator for the Nuclear Hormone Receptor Superfamily Molecular and Cellular Biology ·Zafar Nawaz, David M. Lonard, Carolyn L. Smith, Efrat Lev-Lehman, Sophia Y. Tsai, Ming‐Jer Tsai, Bert W. O’Malley	1999	361
5	The Expanding Cosmos of Nuclear Receptor Coactivators Cell ·David M. Lonard, Bert W. O’Malley	2006	250
6	Nuclear Receptor Coregulators and Human Disease Endocrine Reviews ·David M. Lonard, Rainer B. Lanz, Bert W. O’Malley	2007	225
7	Ubiquitin- and ATP-Independent Proteolytic Turnover of p21 by the REGγ-Proteasome Pathway Molecular Cell ·Xiaotao Li, Larbi Amazit, Weiwen Long, David M. Lonard, John J. Monaco, Bert W. O’Malley	2007	221
8	The SRC-3/AIB1 Coactivator Is Degraded in a Ubiquitin- and ATP-Independent Manner by the REGγ Proteasome Cell ·Xiaotao Li, David M. Lonard, Sung Yun Jung, Anna Malovannaya, Qin Feng, Jun Qin, Sophia Y. Tsai, Ming‐Jer Tsai, Bert W. O’Malley	2006	216
9	Nuclear receptor coregulators: modulators of pathology and therapeutic targets Nature Reviews Endocrinology ·David M. Lonard, Bert W. O’Malley	2012	202
10	Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover Proceedings of the National Academy of Sciences ·Chuandong Geng, Bin He, Limei Xu, Christopher E. Barbieri, Vijay Kumar Eedunuri, Sue Anne Chew, Martin Zimmermann, Richard A. Bond, John Shou, Chao Li, Mirjam Blattner, David M. Lonard, Francesca Demichelis, Cristian Coarfa, Mark A. Rubin, Pengbo Zhou, Bert W. O’Malley, Nicholas Mitsiades	2013	185
11	SRC-3 Coactivator Functional Lifetime Is Regulated by a Phospho-Dependent Ubiquitin Time Clock Cell ·Ray‐Chang Wu, Qin Feng, David M. Lonard, Bert W. O’Malley	2007	181
12	Nuclear Receptor Coactivators: Master Regulators of Human Health and Disease Annual Review of Medicine ·Subhamoy Dasgupta, David M. Lonard, Bert W. O’Malley	2013	154
13	Bufalin Is a Potent Small-Molecule Inhibitor of the Steroid Receptor Coactivators SRC-3 and SRC-1 Cancer Research ·Ying Wang, David M. Lonard, Yang Yu, Dar‐Chone Chow, Timothy Palzkill, Jin Wang, Ruogu Qi, Alexander J. Matzuk, Xianzhou Song, Franck Madoux, Peter Hodder, Peter Chase, Patrick R. Griffin, Suoling Zhou, Lan Liao, Jianming Xu, Bert W. O’Malley	2014	146
14	Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions Steroids ·David M. Lonard, C. Smith	2002	135
15	Expanding functional diversity of the coactivators Trends in Biochemical Sciences ·David M. Lonard, Bert W. O’Malley	2005	130
16	A Repressive Role for Prohibitin in Estrogen Signaling Molecular Endocrinology ·Bin He, Qin Feng, Atish Mukherjee, David M. Lonard, Francesco J. DeMayo, Benita S. Katzenellenbogen, John P. Lydon, Bert W. O’Malley	2007	113
17	Drug Combination in Cancer Treatment—From Cocktails to Conjugated Combinations Cancers ·Yosi Gilad, Gary Gellerman, David M. Lonard, Bert W. O’Malley	2021	101
18	Small Molecule Inhibition of the Steroid Receptor Coactivators, SRC-3 and SRC-1 Molecular Endocrinology ·Ying Wang, David M. Lonard, Yang Yu, Dar‐Chone Chow, Timothy Palzkill, Bert W. O’Malley	2011	100
19	ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion Journal of Clinical Investigation ·Weiwen Long, Charles E. Foulds, Jun Qin, Jian Liu, Ding Chen, David M. Lonard, Luisa M. Solis, Ignacio I. Wistuba, Sophia Y. Tsai, Ming‐Jer Tsai, Bert W. O’Malley	2012	98
20	Proteomic Analysis of Coregulators Bound to ERα on DNA and Nucleosomes Reveals Coregulator Dynamics Molecular Cell ·Charles E. Foulds, Qin Feng, Ding Chen, Suzanna Bailey, Tamra L. Hunsaker, Anna Malovannaya, Ross A. Hamilton, Leah Gates, Zheng Zhang, Chunshu Li, Doug W. Chan, Amol O. Bajaj, Celetta Callaway, Dean P. Edwards, David M. Lonard, Sophia Y. Tsai, Ming‐Jer Tsai, Jun Qin, Bert W. O’Malley	2013	87

About David M. Lonard

David M. Lonard is a scholar working on Molecular Biology, Genetics, Oncology, Immunology and Cancer Research, having authored 89 papers that have together received 6.0k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (42 papers), Ubiquitin and proteasome pathways (19 papers), Cytokine Signaling Pathways and Interactions (13 papers), Protein Degradation and Inhibitors (12 papers), Reproductive System and Pregnancy (9 papers), Genomics and Chromatin Dynamics (9 papers), Retinoids in leukemia and cellular processes (7 papers) and RNA Research and Splicing (7 papers). The work is most often cited by research in Genetics (2.6k citations), Molecular Biology (3.8k citations), Oncology (1.3k citations), Cancer Research (669 citations) and Immunology (669 citations). David M. Lonard has collaborated with scholars based in United States, China and Israel. Frequent co-authors include Bert W. O’Malley, Zafar Nawaz, Carolyn L. Smith, Sophia Y. Tsai, Ming‐Jer Tsai, Qin Feng, Rainer B. Lanz, C. Smith, Yang Yu and Xiaotao Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular Cell, Molecular Endocrinology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

David M. Lonard

Impact in

Papers in i

In The Last Decade

David M. Lonard

Peers

Countries citing papers authored by David M. Lonard

Fields of papers citing papers by David M. Lonard

All Works

About David M. Lonard

Explore authors with similar magnitude of impact

Papers in